Skip to main content

Table 1 Sociodemographic and clinical characteristics of study participants on DTG-based ART in Mengo Hospital, Kampala, Uganda, 2022 (n = 341)

From: Dyslipidemia among adult people living with HIV on dolutegravir – based antiretroviral therapy at a private tertiary hospital in Kampala, Uganda: burden and determinants

Variable

Median (Q1, Q3)

All n (%)

Sex

Female

 

228 (66.9)

Age

 

43 (36, 50)

 

Marital status

Married

 

187 (54.8)

 

Unmarried

 

154 (45.2)

Education level

None

 

21 (6.2)

 

Primary

 

112 (32.8)

 

Secondary

 

149 (43.7)

 

Tertiary

 

59 (17.3)

Employment status

Unemployed

 

35 (10.3)

 

Formally employed

 

54 (15.8)

 

Self employed

 

224 (65.7)

 

Informally employed

 

28 (8.2)

Residence

Rural

 

243 (71.3)

 

Urban

 

98 (28.7)

Smoking history

Yes

 

3 (0.9)

Alcohol use

Yes

 

72 (21.1)

Physical activity

Low

 

209 (61.3)

BMI

Normal

 

145 (42.5)

 

Overweight

 

94 (27.6)

 

Obese

 

102 (29.9)

HTN (by BP)

Yes

 

66 (19.4)

FBG (≥ 7mmol/L)

High

 

18 (5.3)

Baseline CD4* (n = 340)

 

296 (149, 468)

 

DTG duration (months)

 

35.4 (23.8, 40.6)

 

HIV duration (years)

 

9.5 (4.9, 12.7)

 

Previous ART regimen

   
 

NNRTI based

 

282 (82.7)

 

PI based

 

16 (4.7)

 

None

 

43 (12.6)

Current ART regimen

   
 

ABC/3TC/DTG

 

7 (2.1)

 

AZT/3TC/DTG

 

5 (1.5)

 

TDF/3TC/DTG

 

329 (96.5)

Familial DM

No

 

259 (76.0)

Familial HTN

No

 

227 (66.6)

  1. * Missing data, n - number of participants, Q1–1st quartile, Q3–3rd quartile, BMI – body mass index, 3TC - lamivudine, TDF - tenofovir, AZT - zidovudine, ABC - abacavir, DTG - dolutegravir, NNRTI – non-nucleoside reverse transcriptase inhibitor, PI – protease inhibitor, HTN- hypertension, WHO - World Health Organization, ART - antiretroviral therapy, FBG - fasting blood glucose, DM - diabetes mellitus, BP-blood pressure measurement